Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 41, 1981 - Issue sup156
Submit an article Journal homepage
5
Views
41
CrossRef citations to date
0
Altmetric
Original Article

Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive hisease Effects of pentoxifylline

B. Angelkort II Department of Internal Medicine, and Department of Physiology, Rheinisch-Westfälische Technische Hochschule (University) Aachen, West Germany
&
H. Kiesewetter II Department of Internal Medicine, and Department of Physiology, Rheinisch-Westfälische Technische Hochschule (University) Aachen, West Germany
Pages 185-188 | Published online: 08 Jul 2009

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Calogero Barbarino. (1992) Pentoxifylline in the treatment of venous leg ulcers. Current Medical Research and Opinion 12:9, pages 547-551.
Read now

Articles from other publishers (40)

Jesus Meza-Arroyo, Alejandro Bravo-Cuellar, Luis Felipe Jave-Suárez, Georgina Hernández-Flores, Pablo Ortiz-Lazareno, Adriana Aguilar-Lemarroy, Marlin Padilla-Corona, Fernando Sanchez-Zubieta & Oscar Gonzalez-Ramella. (2018) Pentoxifylline Added to Steroid Window Treatment Phase Modified Apoptotic Gene Expression in Pediatric Patients With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 40:5, pages 360-367.
Crossref
Michael Sobel & Raymond Verhaeghe. (2008) Antithrombotic Therapy for Peripheral Artery Occlusive Disease. Chest 133:6, pages 815S-843S.
Crossref
Ján Ürge, Jan Strojil & Petr Utíkal. (2005) PHARMACOTHERAPEUTICAL APPROACHES TO DECREASING HEMATOCRIT AND INCREASING CLAUDICATION DISTANCE IN DIABETIC PATIENTS WITH PERIPHERAL VASCULAR DISEASE. Biomedical Papers 149:2, pages 267-270.
Crossref
G. Patrick Clagett, Michael Sobel, Mark R. Jackson, Gregory Y.H. Lip, Marco Tangelder & Raymond Verhaeghe. (2004) Antithrombotic Therapy in Peripheral Arterial Occlusive Disease. Chest 126:3, pages 609S-626S.
Crossref
David L Dawson. (2001) Comparative effects of cilostazol and other therapies for intermittent claudication. The American Journal of Cardiology 87:12, pages 19-27.
Crossref
Mark R. Jackson & G. Patrick Clagett. (2001) Antithrombotic Therapy in Peripheral Arterial Occlusive Disease. Chest 119:1, pages 283S-299S.
Crossref
Thomas D. Stamos & Robert S. Rosenson. (1999) Low high density lipoprotein levels are associated with an elevated blood viscosity. Atherosclerosis 146:1, pages 161-165.
Crossref
Mark R. Jackson & G. Patrick Clagett. (1998) Antithrombotic Therapy in Peripheral Arterial Occlusive Disease. Chest 114:5, pages 666S-682S.
Crossref
J.P. Simanonok. (1996) Non-ischemic hypoxia of the arterial wall is a primary cause of atherosclerosis. Medical Hypotheses 46:2, pages 155-161.
Crossref
G. Patrick Clagett & William C. Krupski. (1995) Antithrombotic Therapy in Peripheral Arterial Occlusive Disease. Chest 108:4, pages 431S-443S.
Crossref
E. Ernst. (2016) Pentoxifylline for Intermittent Claudication. Angiology 45:5, pages 339-345.
Crossref
K.C. NOZ, M.J. KORSTANJE & B.J. VERMEER. (1993) Ulcerating necrobiosis lipoidica effectively treated with pentoxifylline. Clinical and Experimental Dermatology 18:1, pages 78-79.
Crossref
G. Ciuffetti, M. Mercuri, C. Ott, R. Lombardini, R. Paltriccia, G. Lupattelli, L. Santambrogio & E. Mannarino. (1991) Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. European Journal of Clinical Pharmacology 41:6, pages 511-515.
Crossref
A. M. Jennings, I. Ford, S. Murdoch, M. Greaves, F. E. Preston & J. D. Ward. (1991) The Effects of Diet and Insulin Therapy on Coagulation Factor VII, Blood Viscosity, and Platelet Release Proteins in Diabetic Patients with Secondary Sulphonylurea Failure. Diabetic Medicine 8:4, pages 346-353.
Crossref
Myron H. Luria, Jacob Erel, Dan Sapoznikov & Mervyn S. Gotsman. (1991) Cardiovascular risk factor clustering and ratio of total cholesterol to high-density lipoprotein cholesterol in angiographically documented coronary artery disease. The American Journal of Cardiology 67:1, pages 31-36.
Crossref
John Kokesh, Andris Kazmers & R. Eugene Zierler. (1991) Pentoxifylline in the Nonoperative Management of Intermittent Claudication. Annals of Vascular Surgery 5:1, pages 66-70.
Crossref
J. Koscielny, H. Kiesewetter, F. Jung & A. Haaß. 1991. Hämodilution. Hämodilution 253 282 .
Albrecht Michael EhrlyAlbrecht Michael Ehrly. 1991. Therapeutic Hemorheology. Therapeutic Hemorheology 259 293 .
F. Jung & H. Kiesewetter. 1991. Aktuelle Therapieprinzipien bei der peripheren arteriellen Verschlußkrankheit. Aktuelle Therapieprinzipien bei der peripheren arteriellen Verschlußkrankheit 199 215 .
G de SimoneR B DevereuxS ChienM H AldermanS A AtlasJ H Laragh. (1990) Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults.. Circulation 81:1, pages 107-117.
Crossref
John A. SpittellJr.Jr.. (1990) Diagnosis and management of occlusive peripheral arterial disease. Current Problems in Cardiology 15:1, pages 1-35.
Crossref
Rolf Schneider. (2016) Results of Hemorheologically Active Treatment with Pentoxifylline in Patients with Cerebrovascular Disease. Angiology 40:11, pages 987-993.
Crossref
M. Michal, N. Giessinger & R. Schröer. (1989) Reduced thrombus formation in vivo after administration of pentoxifylline (TrentalR). Thrombosis Research 56:3, pages 359-368.
Crossref
Albrecht Michael EhrlyAlbrecht Michael Ehrly. 1989. Therapeutische Hämorheologie. Therapeutische Hämorheologie 271 305 .
E. Ott, E. Körner & H. Lechner. (2016) Hemorheologic Treatment of Cerebral Reversible Ischemic Episodes with Pentoxifylline — A Prospective Study. Angiology 39:6, pages 520-525.
Crossref
Jerald Insel, A. Arthur Halle & David M. Mirvis. (2016) Efficacy of Pentoxifylline in Patients with Stable Angina Pectoris. Angiology 39:6, pages 514-519.
Crossref
C Y HsuJ W NorrisE L HoganP BladinH B DinsdaleF M YatsuM P EarnestP ScheinbergL R CaplanH R Karp. (1988) Pentoxifylline in acute nonhemorrhagic stroke. A randomized, placebo-controlled double-blind trial.. Stroke 19:6, pages 716-722.
Crossref
Gail Tominaga, Kenneth Waxman, M.Hani Soliman, I.James Sarfeh, H.X. Bui & Andrzej Tarnawski. (1988) Protective effect of pentoxifylline on gastric mucosa. Journal of Surgical Research 44:6, pages 727-732.
Crossref
Sotos Raptis, Asimina Mitrakou, Dimitrios Hadjidakis, Emmanuel Diamantopoulos, Costas Anastasiou, Artemis Fountas & Roland Müller. (1987) 24-h blood glucose pattern in type I and type II diabetics after oral treatment with pentoxifylline as assessed by artificial endocrine pancreas. Acta Diabetologica Latina 24:3, pages 181-192.
Crossref
J. J. Jukna & C. D. Nicholson. (1987) The effect of denbufylline on the viscosity of rat whole blood and on the deformability (filterability) of rat blood cell suspensions. Naunyn-Schmiedeberg's Archives of Pharmacology 335:4, pages 445-448.
Crossref
R.V. Manrique & V. Manrique. (2016) Platelet Resistance to Prostacyclin. Enhancement of the Antiaggregatory Effect of Prostacyclin by Pentoxifylline. Angiology 38:2, pages 101-108.
Crossref
John A. Dormandy. 1986. Clinical Hemorheology. Clinical Hemorheology 165 194 .
Jerry Goldberg & Andrea Dlesk. (2005) Successful treatment of Raynaud's phenomenon with pentoxifylline. Arthritis & Rheumatism 29:8, pages 1055-1056.
Crossref
F. Jean, A. Aubert, F. Bloch, J. P. Petite, P. Priollet, J. N. Fiessinger, J. M. Husson & E. Billaud. (2005) Effects of diltiazem versus nifedipine on lower esophageal sphincter pressure in patients with progressive systemic sclerosis. Arthritis & Rheumatism 29:8, pages 1054-1055.
Crossref
H. Kiesewetter, F. Jung, K. H. Ladwig, E. Waterloh, P. Roebruck, R. Schneider, G. Kotitschke & R. Bach. (1986) Prädiktorfunktion hämorheologischer Parameter im Hinblick auf die Inzidenz manifester Durchblutungsstörungen: Konzept der Aachen-StudiePredictability of hemorheological parameters with respect to the incidence of vascular disease: Concept of the Aachen-study. Klinische Wochenschrift 64:14, pages 653-662.
Crossref
Reiner H. Schröer. (2016) Antithrombotic Potential of Pentoxifylline A Hemorheologically Active Drug. Angiology 36:6, pages 387-398.
Crossref
B. Angelkort, P. Spürk, A. Habbaba & M. Mähder. (2016) Blood Flow Properties and Walking Performance in Chronic Arterial Occlusive Disease. Angiology 36:5, pages 285-292.
Crossref
Roland Mueller. (2016) On the Therapy of Disturbances of Blood Fluidity. Angiology 36:4, pages 226-234.
Crossref
J. Stuart & J. Marshall. 1985. Supportive therapy in haematology. Supportive therapy in haematology 351 364 .
Domingo M. Aviado & Harold R. Dettelbach. (2016) Pharmacology of Pentoxifylline A Hemorheologic Agent for the Treatment of Intermittent Claudication. Angiology 35:7, pages 407-417.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.